RecruitingNCT06639373

The Road to Recovery Initiative (R2RI)

The Road to Recovery Initiative (R2RI): an Observational Study of a Novel Model of Substance Use Care in a Canadian Setting


Sponsor

BC Centre on Substance Use

Enrollment

10,000 participants

Start Date

Oct 5, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Despite substance use causing significant harms and cost to our health care system, British Columbia's (BC) current addiction treatment system remains under-resourced and fragmented. To address this, Providence Health Care (PHC) is expanding clinical addiction services as part of the Road to Recovery Initiative (R2R). The proposed study aims to generate novel data to promote fully evidence-informed and coordinated substance use care in BC and beyond. This study will explore substance use treatment trajectories, identify challenges and areas for growth in addiction health services, characterize important features of patients accessing care, and improve our provincial capacity to promptly tailor approaches to care in response to the substance use crisis.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Aged 18 years or older
  • Able to provide written informed consent
  • A resident of British Columbia
  • Willing to comply with study procedures
  • An individual who has accessed one or more R2R services

Exclusion Criteria2

  • Individuals who have an acute, severe mental health condition (e.g., psychosis) precluding the opportunity to provide full informed consent
  • Individuals who have an acute, severe medical condition (e.g., intubation) precluding the opportunity to provide full informed consent

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSpecialized clinical service access

A new model of addiction care that will offer comprehensive and coordinated service delivery


Locations(1)

St. Paul's Hospital - Providence Health Care

Vancouver, British Columbia, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06639373


Related Trials